STAGE III MELANOMA
Clinical trials for STAGE III MELANOMA explained in plain language.
Never miss a new study
Get alerted when new STAGE III MELANOMA trials appear
Sign up with your email to follow new studies for STAGE III MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to shrink melanoma before surgery
Disease control OngoingThis phase II trial tests two drugs, pembrolizumab and lenvatinib, given before surgery to people with stage III melanoma that can be removed. The goal is to see if the combination can shrink or eliminate the tumor before the operation. Twenty-one participants will receive the dr…
Matched conditions: STAGE III MELANOMA
Phase: PHASE2 • Sponsor: Melanoma Institute Australia • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Immunotherapy after surgery may keep melanoma at bay
Disease control OngoingThis study tested whether giving the immunotherapy drug pembrolizumab after surgery helps prevent melanoma from returning in people with high-risk stage III melanoma. About 1,000 participants received either pembrolizumab or a placebo for up to a year. The main goal was to see if…
Matched conditions: STAGE III MELANOMA
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC